Literature DB >> 12425471

Particle interactions involved in aerosol dispersion of ternary interactive mixtures.

Margaret D Louey1, Peter J Stewart.   

Abstract

PURPOSE: To investigate the mechanism of action of ternary components within dry powder aerosols.
METHODS: Ternary interactive mixtures were prepared containing salbutamol sulphate (SS), coarse lactose carriers and either micronized lactose (ML) or micronized glucose (MG). In vitro drug and excipient aerosol deposition was performed using a twin-stage impinger (TSI) at 60 L/min with a Rotahaler device. Adhesional properties of the lactose carrier were examined using an atomic force microscope (AFM) colloidal probe technique. RESULT: The fine particle fraction (FPF) from ternary mixtures were dependent upon carrier type (p < 0.001), ternary concentration (p < 0.001) and ternary component type (p < 0.05). Ternary mixtures produced higher FPF than binary mixtures, except those containing Superfine (SF), which was attributed to the high proportion of intrinsic fine carrier particles. The higher FPF obtained from ternary mixtures was independent of the mixing order (p = 0.08). Increased adhesion force was observed on the carrier surface following the addition of ternary components (p < 0.001).
CONCLUSION: The results confirm that ternary components increase aerosol deposition of powder mixtures. Some results were not entirely consistent with the saturation of active site theory and a hypothesis involving competitive and multilayer adhesion was proposed and requires further testing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12425471     DOI: 10.1023/a:1020464801786

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  6 in total

1.  Characterisation of small changes in the physical properties of powders of significance for dry powder inhaler formulations.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1997-06-09       Impact factor: 15.470

2.  The use of different grades of lactose as a carrier for aerosolised salbutamol sulphate.

Authors:  H Larhrib; X M Zeng; G P Martin; C Marriott; J Pritchard
Journal:  Int J Pharm       Date:  1999-11-25       Impact factor: 5.875

3.  The influence of lactose carrier on the content homogeneity and dispersibility of beclomethasone dipropionate from dry powder aerosols.

Authors:  X M Zeng; K H Pandhal; G P Martin
Journal:  Int J Pharm       Date:  2000-03-20       Impact factor: 5.875

4.  Protein deposition from dry powder inhalers: fine particle multiplets as performance modifiers.

Authors:  P Lucas; K Anderson; J N Staniforth
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

5.  Interparticle forces in binary and ternary ordered powder mixes.

Authors:  J N Staniforth; J E Rees; F K Lai; J A Hersey
Journal:  J Pharm Pharmacol       Date:  1982-03       Impact factor: 3.765

6.  Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation.

Authors:  X M Zeng; G P Martin; S K Tee; A A Ghoush; C Marriott
Journal:  Int J Pharm       Date:  1999-05-25       Impact factor: 5.875

  6 in total
  22 in total

1.  Powder strength distributions for understanding de-agglomeration of lactose powders.

Authors:  Shyamal C Das; Srinivas Ravindra Babu Behara; Jurgen B Bulitta; David A V Morton; Ian Larson; Peter J Stewart
Journal:  Pharm Res       Date:  2012-06-14       Impact factor: 4.200

2.  Agglomerate strength and dispersion of salmeterol xinafoate from powder mixtures for inhalation.

Authors:  Handoko Adi; Ian Larson; Herbert Chiou; Paul Young; Daniela Traini; Peter Stewart
Journal:  Pharm Res       Date:  2006-09-14       Impact factor: 4.200

3.  Influence of air flow on the performance of a dry powder inhaler using computational and experimental analyses.

Authors:  Matthew S Coates; Hak-Kim Chan; David F Fletcher; Judy A Raper
Journal:  Pharm Res       Date:  2005-08-24       Impact factor: 4.200

4.  The mode of drug particle detachment from carrier crystals in an air classifier-based inhaler.

Authors:  Anne H de Boer; Paul Hagedoorn; Doetie Gjaltema; Dorette Lambregts; Meike Irngartinger; Henderik W Frijlink
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 5.  The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations.

Authors:  Matthew D Jones; Robert Price
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 6.  Particle size analysis in pharmaceutics: principles, methods and applications.

Authors:  Boris Y Shekunov; Pratibhash Chattopadhyay; Henry H Y Tong; Albert H L Chow
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

Review 7.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

8.  An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces.

Authors:  Matthew D Jones; Jennifer C Hooton; Michelle L Dawson; Alan R Ferrie; Robert Price
Journal:  Pharm Res       Date:  2007-10-19       Impact factor: 4.200

9.  The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.

Authors:  Jagdeep Shur; Haggis Harris; Matthew D Jones; J Sebastian Kaerger; Robert Price
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

10.  Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures?

Authors:  Nazrul Islam; Peter Stewart; Ian Larson; Patrick Hartley
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.